Results 101 to 110 of about 34,055 (177)

Non-Candida isolates from blood cultures and intra-abdominal samples: data derived from a multicentre prospective study conducted in Madrid. [PDF]

open access: yesRev Esp Quimioter, 2023
Díaz-García J   +19 more
europepmc   +1 more source

One-year consolidation with Ponatinib 15 mg in chronic myeloid leukaemia on deep molecular response with Imatinib. [PDF]

open access: yesAnn Hematol
Pérez-Lamas L   +21 more
europepmc   +1 more source

Quizartinib for Newly Diagnosed <i>FLT3</i>-Internal Tandem Duplication-Negative AML: The Randomized, Double-Blind, Placebo-Controlled, Phase II QUIWI Study. [PDF]

open access: yesJ Clin Oncol
Montesinos P   +51 more
europepmc   +1 more source

Correction: Díaz-García et al. Candida Genotyping of Blood Culture Isolates from Patients Admitted to 16 Hospitals in Madrid: Genotype Spreading during the COVID-19 Pandemic Driven by Fluconazole-Resistant C. parapsilosis. J. Fungi 2022, 8, 1228. [PDF]

open access: yesJ Fungi (Basel), 2023
Díaz-García J   +19 more
europepmc   +1 more source

Mutational screening of newly diagnosed multiple myeloma patients by deep targeted sequencing

open access: yesHaematologica, 2018
Yanira Ruiz-Heredia   +28 more
doaj   +1 more source

Los panegiristas (?) de Joyce [PDF]

open access: yes, 1997
Pérez de Ayala, Ramón
core  

Response rate and long-term survival in patients with advanced melanoma: data from the prospective cohort study gem-1801. [PDF]

open access: yesClin Transl Oncol
Espinosa E   +32 more
europepmc   +1 more source

El pregonero de Joyce [PDF]

open access: yes, 1997
Pérez de Ayala, Ramón
core  

Trends in antifungal resistance in Candida from a multicenter study conducted in Madrid (CANDIMAD study): fluconazole-resistant C. parapsilosis spreading has gained traction in 2022. [PDF]

open access: yesAntimicrob Agents Chemother, 2023
Díaz-García J   +17 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy